An artificial insemination is the medical process used to achieve pregnancy by intentionally introducing sperm in the uterus of the female by means different from sexual intercourse. Artificial insemination is the process of fertility treatment for humans, which is a common practice in animal breeding. Artificial insemination recipients include infertile couples and single mothers. Intrauterine Insemination (IUI) is a widely used method in artificial insemination. Rising incidence of infertility is the key factor expected to drive growth of the global artificial insemination market. For instance, as per the 2012 PLOS Medicine published research, over 48.5 Mn couples globally were impotent at conceiving a child, in 2010. Players in the market often provide home-use kits, such as ovulation kits, insemination devices, and pregnancy detection kits.
Get PDF Brochure with COVID19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-pdf/1793
Global Artificial Insemination Market Dynamics
Key pharmaceutical players are engaged in development of products, in preclinical and clinical trials along with launching latest insemination kits which have showed potential benefits, which in turn, is expected to propel the global artificial insemination market growth over the forecast period. For instance, clinical trial of the Stork OTC kit, in 2015, showed efficacy at delivering high sperm concentration to cervix, as compared to natural intercourse. Stork OTC delivered a 3.23 times higher sperm concentration value to over 85% subjects within the study, however, the rest 15% exhibited no sperm concentration change at cervix. Stork OTC was approved by the U.S. FDA for over-the-counter sell, in July 2014. This kit helps in collecting, inserting, and transporting sperms directly to the cervix opening for a prolonged duration, offering sperms the chance for entering in the uterus. Stork OTC offers a simple and safe way to users for avoiding unsuital vaginal environment, for delivering the sperm.
However, as per the National Women’s Health Resource Center, over 20 Mn women are impacted by infertility. As per the 2017 report by United Nations World Population prospects, complete fertility is expected to reduce to 2.39 from 2.43 (children per woman) from 2020 to 2030. Increasing infertility incidence among the worldwide populace is expected to boost the global artificial insemination market growth over the forecast period.
However, strict regulations implemented by major countries related to who is suitable for receiving fertility treatment, is expected to hinder the global artificial insemination market growth over the forecast period. For instance, France and Italy forbid single women and lesbian couples from using the artificial insemination. Austria and Italy are the countries that ban all egg and sperm donations for IVF. Germany and Norway allow sperm donation, however, ban egg donation.
Global Artificial Insemination Market – Regional Insights
Based on geography, the global artificial insemination market is segregated into North America, Europe, Latin America, Asia Pacific, Africa, and Middle East. North America accounts for the largest share in the global artificial insemination market, due to advancements in technology and favorable regulations and rules in this region. For instance, as per the National Conference of State Legislature 2018 report, 14 states comprise of laws that mandating employers to offer insurance for treatment of fertility. Hawaii, Arkansas, Maryland, and Texas mandate coverage of only in vitro fertilization, excluding inseminations.
Moreover, Asia Pacific is expected to register robust growth due to increasing incidence of infertility in the populace along with less strict regulations. For instance, as per the 2015 report by United Nation Department of Economic and Social Affairs, a decline in fertility rate from around 1.3 to 1.4 children/woman was observed.
Global Artificial Insemination Market – Competitive Landscape
Major players functioning in the global artificial insemination market are Pride Angel, Hi-Tech Solutions, Irvine Scientific, Rinovum Women’s Health, LLC, Conceivex, Inc., TenderNeeds Fertility, Labotech GmbH, Biogenics Inc., Hamilton Throne Ltd., Nikon Instruments Inc., Surelife Pte Ltd., and Zander scientific Inc. Major players are adopting growth strategies including acquisition, collaborations, and novel product launches for maintaining a their position within the market. For instance, Worthington Industries, collaborated with Intellectual Ventures, in 2016, to launch the novel AIS 1.5 and AIS 3 artificial insemination shield refrigerators enabled with the modified artificial insemination shield canisters to hold samples.
Global Artificial Insemination Market Taxonomy
Based on procedure type,
• Intrauterine Insemination
• Intravaginal Insemination
• Intracervical Insemination
• Intratubal Insemination
Based on product type,
• Home Conception Devices
• Insemination Kits
Based on end user,
• Fertility Centers
Based on geography,
• North America
• Latin America
• Asia Pacific
• Middle East
Purchase This Premium Report Here With Discounted Price (Flat US $2000 Off) – https://www.coherentmarketinsights.com/promo/buynow/1793
Reasons to Purchase this Report
• Current and future of global Artificial Insemination market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027